NCT02892318: A Study Evaluating the Safety and Pharmacology of Atezolizumab Administered in Combination With Immunomodulatory Agents in Participants With Acute Myeloid Leukemia (AML) |
|
|
| Completed | 1 | 40 | US | Atezolizumab, MPDL3280A;, Tecentriq, Guadecitabine | Hoffmann-La Roche | Acute Myeloid Leukemia | 12/19 | 12/19 | | |
LAM-002A/NHL, NCT02594384: A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma |
|
|
| Completed | 1 | 62 | US | LAM-002A, apilimod dimesylate, Rituximab, rituxan, Atezolizumab, Tecentriq | AI Therapeutics, Inc. | Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic | 03/20 | 03/23 | | |
